This is the second part of our discussion on the evolution of artificial intelligence and its impact on life sciences with guests from Microsoft and IQVIA.
We dive into regulation, real-time management, and AI's various applications and how it can streamline different processes.
We also discuss the cost and affordability of AI; the tremendous investment required and when holding off on new tech is valuable.
Hear how AI is highlighting society's flaws and may become the catalyst for societal change.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Matt O’Donnell, Industry Executive Health & Life Sciences, Microsoft
Mike King, Senior Director of Product and Strategy, IQVIA